Adverum Biotechnologies I... (ADVM)
NASDAQ: ADVM
· Real-Time Price · USD
2.85
-0.08 (-2.73%)
At close: Aug 19, 2025, 3:59 PM
Adverum Biotechnologies Revenue
Adverum Biotechnologies reported an annual revenue of $1M, reflecting a -72.22% growth. For the quarter ending June 30, 2025, Adverum Biotechnologies generated $0 in revenue.
Revenue (ttm)
1M
Revenue Growth
-72.22%
Price / Sales Ratio
92.38
Revenue / Employee
6.45K
Employees
155
Market Cap
59.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 1M | -72.22% |
| Dec 31, 2023 | 3.6M | +Infinity% |
| Dec 31, 2022 | 0 | -100.00% |
| Dec 31, 2021 | 7.5M | +Infinity% |
| Dec 31, 2020 | 0 | -100.00% |
| Dec 31, 2019 | 250K | -84.49% |
| Dec 31, 2018 | 1.61M | -12.82% |
| Dec 31, 2017 | 1.85M | +27.08% |
| Dec 31, 2016 | 1.46M | -37.26% |
| Dec 31, 2015 | 2.32M | +305.42% |
| Dec 31, 2014 | 572K | +19.17% |
| Dec 31, 2013 | 480K | +1500.00% |
| Dec 31, 2012 | 30K | n/a |